John Markels
Förmögenhet: 11 778 $ per 2026-08-31
Förmögenhet: 11 778 $ per 2026-08-31
Dr. John H.
Markels is an Independent Director at Vaxcyte, Inc., an Independent Director at Arcturus Therapeutics Holdings, Inc. and an Independent Director at Sangamo Therapeutics, Inc. He is on the Board of Directors at Vaxcyte, Inc., Arcturus Therapeutics Holdings, Inc., Sangamo Therapeutics, Inc., Arcturus Therapeutics Ltd. and Arcturus Therapeutics, Inc. Dr. Markels was previously employed as a President-Global Vaccines by Merck & Co., Inc. He received his undergraduate degree from the University of Delaware and a doctorate degree from the University of California, Berkeley.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-04-20 | 71 384 ( 0,02 % ) | 11 778 $ | 2026-08-31 | |
| 2026-06-05 | 0 ( -.--% ) | - $ | 2026-08-31 |
| Företag | Position | Start |
|---|---|---|
| SANGAMO THERAPEUTICS, INC. | Direktör/Styrelseledamot | 2020-02-11 |
| ARCTURUS THERAPEUTICS HOLDINGS INC. | Direktör/Styrelseledamot | 2022-12-08 |
| VAXCYTE, INC. | Direktör/Styrelseledamot | 2026-07-16 |
Arcturus Therapeutics, Inc.
Arcturus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops technology and therapeutics for rare diseases | Direktör/Styrelseledamot | - |
Arcturus Therapeutics Ltd.
Arcturus Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops technology and therapeutics for rare diseases | Direktör/Styrelseledamot | - |
| Företag | Position | Slut |
|---|---|---|
| MERCK & CO., INC. | Företagsledare/Principal | 2022-03-01 |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 8 |
|---|---|
Merck & Co., Inc.
Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Sangamo Therapeutics, Inc.
Sangamo Therapeutics, Inc. BiotechnologyHealth Technology Operates as a genomic medicine company | Health Technology |
Arcturus Therapeutics, Inc.
Arcturus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops technology and therapeutics for rare diseases | Health Technology |
University of California, Berkeley
University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Delaware
University of Delaware Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vaxcyte, Inc.
Vaxcyte, Inc. BiotechnologyHealth Technology Develops vaccines for infectious diseases | Health Technology |
Arcturus Therapeutics Ltd.
Arcturus Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops technology and therapeutics for rare diseases | Health Technology |
Arcturus Therapeutics Holdings, Inc.
Arcturus Therapeutics Holdings, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån